132 related articles for article (PubMed ID: 24292643)
21. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia.
Nanri K; Okita M; Takeguchi M; Taguchi T; Ishiko T; Saito H; Otsuka T; Mitoma H; Koizumi K
Intern Med; 2009; 48(10):783-90. PubMed ID: 19443972
[TBL] [Abstract][Full Text] [Related]
22. Anti-glutamic acid decarboxylase limbic encephalitis without epilepsy evolving into dementia with cerebellar ataxia.
Mirabelli-Badenier M; Morana G; Pinto F; Uccelli A; Veneselli E; Battaglia FM; Biancheri R; Baglietto MG; Vincent A; Mancardi MM
Arch Neurol; 2012 Aug; 69(8):1064-6. PubMed ID: 22507885
[TBL] [Abstract][Full Text] [Related]
23. Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies.
Vianello M; Tavolato B; Armani M; Giometto B
Cerebellum; 2003; 2(1):77-9. PubMed ID: 12882238
[TBL] [Abstract][Full Text] [Related]
24. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
[TBL] [Abstract][Full Text] [Related]
25. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
Lorenzoni PJ; Scola RH; Lang B; Kay CS; Teive HA; Kowacs PA; Werneck LC
J Neurol Sci; 2008 Jul; 270(1-2):194-6. PubMed ID: 18374949
[TBL] [Abstract][Full Text] [Related]
26. A patient with type 1 diabetes mellitus and cerebellar ataxia associated with high titer of circulating anti-glutamic acid decarboxylase antibodies.
Iwasaki H; Sato R; Shichiri M; Hirata Y
Endocr J; 2001 Apr; 48(2):261-8. PubMed ID: 11456277
[TBL] [Abstract][Full Text] [Related]
27. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase.
Ishida K; Mitoma H; Song SY; Uchihara T; Inaba A; Eguchi S; Kobayashi T; Mizusawa H
Ann Neurol; 1999 Aug; 46(2):263-7. PubMed ID: 10443895
[TBL] [Abstract][Full Text] [Related]
28. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
[TBL] [Abstract][Full Text] [Related]
29. Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review.
Baizabal-Carvallo JF; Alonso-Juarez M
J Neural Transm (Vienna); 2017 Oct; 124(10):1171-1182. PubMed ID: 28689294
[TBL] [Abstract][Full Text] [Related]
30. Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies.
Muñiz-Castrillo S; Vogrig A; Joubert B; Pinto AL; Gonçalves D; Chaumont H; Rogemond V; Picard G; Fabien N; Honnorat J
Cerebellum; 2020 Oct; 19(5):715-721. PubMed ID: 32592031
[TBL] [Abstract][Full Text] [Related]
31. Cerebellar ataxia and nystagmus with GAD antibodies in a woman from the West Indies : a video demonstration.
Ramcharan K; Reyes AJ; Abdool K; Raamkaransingh N
BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31615777
[No Abstract] [Full Text] [Related]
32. Rapidly progressing cerebellar ataxia associated with anti-GAD antibodies.
Quintas S; Ruiz RL; Zapata-Wainberg G; Vivancos J
Neurologia (Engl Ed); 2018 May; 33(4):273-275. PubMed ID: 27091680
[No Abstract] [Full Text] [Related]
33. Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia.
Takenoshita H; Shizuka-Ikeda M; Mitoma H; Song S; Harigaya Y; Igeta Y; Yaguchi M; Ishida K; Shoji M; Tanaka M; Mizusawa H; Okamoto K
J Neurol Neurosurg Psychiatry; 2001 Mar; 70(3):386-9. PubMed ID: 11181864
[TBL] [Abstract][Full Text] [Related]
34. Low-titer anti-GAD-antibody-positive cerebellar ataxia.
Nanri K; Niwa H; Mitoma H; Takei A; Ikeda J; Harada T; Okita M; Takeguchi M; Taguchi T; Mizusawa H
Cerebellum; 2013 Apr; 12(2):171-5. PubMed ID: 22923147
[TBL] [Abstract][Full Text] [Related]
35. Acute Cerebellar Ataxia Associated with Anti-glutamic Acid Decarboxylase Antibodies Mimicking Miller Fisher Syndrome.
Nakamura Y; Nakajima H; Hosokawa T; Yamane K; Ishida S; Kimura F
Intern Med; 2018 Jan; 57(2):269-271. PubMed ID: 29093402
[TBL] [Abstract][Full Text] [Related]
36. Vertical nystagmus associated with glutamic acid decarboxylase antibodies responding to cyclophosphamide.
Baizabal-Carvallo JF; Alonso-Juarez M
J Neuroimmunol; 2018 Apr; 317():5-7. PubMed ID: 29501085
[TBL] [Abstract][Full Text] [Related]
37. Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia.
Ishida K; Mitoma H; Wada Y; Oka T; Shibahara J; Saito Y; Murayama S; Mizusawa H
J Neurol Neurosurg Psychiatry; 2007 Feb; 78(2):190-2. PubMed ID: 17119008
[TBL] [Abstract][Full Text] [Related]
38. [Steroid treatment in four cases of anti-GAD cerebellar ataxia].
Bonnan M; Cabre P; Olindo S; Signate A; Saint-Vil M; Smadja D
Rev Neurol (Paris); 2008 May; 164(5):427-33. PubMed ID: 18555874
[TBL] [Abstract][Full Text] [Related]
39. Clinical Reasoning: A 70-year-old woman with acute-onset weakness and progressive hemiataxia.
Schreck KC; Orthmann-Murphy JL; Newsome SD
Neurology; 2016 Nov; 87(22):e264-e268. PubMed ID: 27895250
[No Abstract] [Full Text] [Related]
40. GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies.
Hosoi Y; Suzuki-Sakao M; Terada T; Konishi T; Ouchi Y; Miyajima H; Kono S
J Neurol; 2013 Dec; 260(12):3086-92. PubMed ID: 24091766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]